Bio Impact Capital LLC Lantheus Holdings, Inc. Transaction History
Bio Impact Capital LLC
- $641 Million
- Q3 2024
A detailed history of Bio Impact Capital LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 150,182 shares of LNTH stock, worth $12.3 Million. This represents 2.57% of its overall portfolio holdings.
Number of Shares
150,182
Previous 150,000
0.12%
Holding current value
$12.3 Million
Previous $12 Million
36.86%
% of portfolio
2.57%
Previous 1.93%
Shares
2 transactions
Others Institutions Holding LNTH
# of Institutions
545Shares Held
70MCall Options Held
673KPut Options Held
454K-
Black Rock Inc. New York, NY8.6MShares$705 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.24MShares$594 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA5.32MShares$436 Million2.53% of portfolio
-
Janus Henderson Group PLC London, X03.59MShares$294 Million0.21% of portfolio
-
State Street Corp Boston, MA2.64MShares$216 Million0.01% of portfolio
About Lantheus Holdings, Inc.
- Ticker LNTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 68,741,904
- Market Cap $5.63B
- Description
- Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...